BioForce Nanosciences Holdings, Inc.
BFNH
$1.50
$0.085.63%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -14.29% | -12.50% | -92.39% | -93.69% | -93.69% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -14.29% | -12.50% | -92.39% | -93.69% | -93.69% |
|
|||||
Total Current Assets | -14.29% | -12.50% | -92.39% | -93.69% | -93.69% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -14.29% | -12.50% | -92.39% | -93.69% | -93.69% |
|
|||||
Total Accounts Payable | 550.00% | 37.50% | 175.00% | -- | -93.65% |
Total Accrued Expenses | 36.05% | 39.61% | 43.97% | 49.40% | 56.36% |
Short-term Debt | 26.77% | 29.75% | 31.10% | 32.19% | 49.83% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 35.01% | 38.29% | 42.22% | 47.01% | 54.41% |
|
|||||
Total Current Liabilities | 35.01% | 38.29% | 42.22% | 47.01% | 54.41% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 26.77% | 29.75% | 31.10% | 32.19% | 49.83% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 35.01% | 38.29% | 42.22% | 47.01% | 54.41% |
|
|||||
Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Retained Earnings | -0.29% | -0.30% | -0.30% | -0.30% | -0.30% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -35.03% | -38.32% | -43.34% | -48.58% | -56.32% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -35.03% | -38.32% | -43.34% | -48.58% | -56.32% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -35.03% | -38.32% | -43.34% | -48.58% | -56.32% |
|